---
title: "SK invests in Standigm for AI-based drug development"
date: November 20, 2019
categories:
  - News
tags:
  - Standigm
  - Investment
---

HONG KONG â€“ SK Holdings Co. Ltd. invested KRW10 billion (US$8.6 million) in Standigm Inc., an artificial intelligence (AI)-powered biotech company based in Seoul, Korea. It is the second big investment Standigm has attracted this year after a KRW13 billion series B round in March.

#### Read more in English press
[Bioworld](https://www.bioworld.com/articles/431257-head-sk-invests-in-standigm-for-ai-based-drug-development?v=preview)
